2023-11-15T13:00:18-06:00 2022-12-31 FORVIS LLP 8200 W Interstate 10 Suite 900 San Antonio TX 782303806 990 2022-01-01 454765222 BIOBRIDGE GLOBAL % BENJAMIN LOPEZ BIOB 2107579505 6211 IH 10 WEST SAN ANTONIO TX 78201 JOHN YOUNGDAHL SVP, CFO 2107579505 2023-11-15 true GLENN KUES 999009999 Roberto Ulloa P01953132 2103419400 2023-11-15 3 2022 2023-04-26 12:10:37Z MARTIN J LANDON 6211 IH 10 WEST SAN ANTONIO TX 78201 70477429 false X WWW.BIOBRIDGEGLOBAL.ORG X 2012 TX BIOBRIDGE GLOBAL(BBG) IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER(STBTC), QUALTEX LABORATORIES (SEE SCH.O) 15 14 223 18 0 0 156277 0 33961743 35567036 1109944 904293 202491 169402 35430455 36640731 355016 368509 0 0 22721121 24913872 0 0 0 8844537 9562447 31920674 34844828 3509781 1795903 72557364 69766084 8813774 13839021 63743590 55927063 X BIOBRIDGE GLOBAL IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (QUALTEX), GENCURE, AND THE BLOOD & TISSUE CENTER FOUNDATION (THE FOUNDATION) - (SEE SCHEDULE O). false false 34844828 368509 35727127 BIOBRIDGE GLOBAL IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (QUALTEX), GENCURE, AND THE BLOOD & TISSUE CENTER FOUNDATION (THE FOUNDATION) BY PROVIDING SUPPORT AND ADMINISTRATIVE FUNCTIONS THAT PROMOTE AND SUPPORT THE CHARITABLE MISSION AND PURPOSES OF STBTC, QUALTEX, GENCURE, AND THE FOUNDATION. 34844828 true false false false false false false false false false true false true false true false false true false false false false false false false false false true false true false false false false false false false false false false false false false true true true false false true 84 0 true 223 true false false false false false false false false false false false false X 15 14 false false false false false false false true true false false false true true true true true true true true false X BENJAMIN LOPEZ 2107579505 6211 IH 10 WEST SAN ANTONIO TX 78201 X MARTIN LANDON EX-OFFICIO DIR/CEO 49.0 1.0 X X 993227 0 41360 WILLIAM RICHEY WYATT SVP/GEN COUNSEL & CHIEF COMP 50.0 0.0 X 432244 0 46475 RACHEL-LOUISE BEDDARD SVP/CHIEF MEDICAL OFFICER 50.0 0.0 X 352564 0 50405 EDWARD CARTER III SVP/CHIEF COMMERCIAL OFFICER 50.0 0.0 X 363836 0 19652 MARK EDWARD FITE SVP, COO, QUALTEX 1.0 49.0 X 0 352904 18750 ADRIENNE MENDOZA SVP/COO, STBTC (EFF 04/22) 1.0 49.0 X 0 299073 27478 JOHN F BARNES IV VP HUMAN RESOURCES & LEARNING 50.0 0.0 X 271904 0 34768 THOMAS SCOTT JONES VP SCIENTIFIC AFFAIRS 50.0 0.0 X 262952 0 41353 BECKY CAP SVP/BUS DEV (EFF 10/22) 12.5 37.5 X 49976 237559 15230 GLENN KUES SVP/CFO (THRU 06/22) 50.0 0.0 X 270068 0 26716 JOHN WILLIAM YOUNGDAHL SVP/CFO (EFF 07/22) 50.0 0.0 X 259219 0 32917 JOSE MURILLO VP INFORMATION TECHNOLOGY 50.0 0.0 X 244922 0 45599 GRANVILLE BETTON SR VP TALENT & PERFORMANCE 50.0 0.0 X 252504 0 35264 SOPHIE BARDY VP MARKETING 50.0 0.0 X 241801 0 27367 CHRISTOPHER JOHNSON VP SUPPLY CHAIN & SUPPORT SERV 50.0 0.0 X 226622 0 39362 ELIZABETH WALTMAN SVP/COO STBTC (THRU 03/22) 1.0 49.0 X 0 212290 14085 EMMANUEL ALEJANDRO CASASOLA EXECUTIVE DIRECTOR, GLOBAL QUA 50.0 0.0 X 205101 0 19475 BENJAMIN LOPEZ SR DIR., FINANCE & ACCOUNTING 50.0 0.0 X 203867 0 15380 CHARLES J LERNER MD FSHEA DIRECTOR 1.0 0.0 X 0 0 0 STEVEN R BROOK JD CHAIR 1.0 0.0 X X 0 0 0 AL RAJWANI DIRECTOR 1.0 0.0 X 0 0 0 DONALD H JENKINS MD FACS DIRECTOR 1.0 0.0 X 0 0 0 GABRIELE NIEDERAUER PHD CHAIR - ELECT/SECRETARY 1.0 0.0 X X 0 0 0 J CHARLENE DAVIS PHD DIRECTOR 1.0 0.0 X 0 0 0 JAMES ROSENBLATT JD DIRECTOR 1.0 0.0 X 0 0 0 JEANNIE FRAZIER DIRECTOR 1.0 0.0 X 0 0 0 JENNA SAUCEDO-HERRERA DIRECTOR 1.0 0.0 X 0 0 0 JOHN FEIK DIRECTOR EMERITUS 1.0 0.0 X 0 0 0 KENNETH GINDY JD DIRECTOR 1.0 0.0 X 0 0 0 KENNETH P TREVETT JD DIRECTOR 1.0 0.0 X 0 0 0 MICHAEL KREAGER JD CHAIR EMERITUS/ASST SECRETARY 1.0 0.0 X X 0 0 0 RANDI BROSTERMAN HUTCHENS VICE-CHAIR & TREASURER 1.0 0.0 X X 0 0 0 THOMAS M MCNISH MD DIRECTOR 1.0 0.0 X 0 0 0 4630807 1101826 551636 53 true true false SHI INTERNATIONAL CORP PO BOX 952121 DALLAS TX 75395 EQUIP & SFTW MAINT 743903 ALLIED UNIVERSAL SECURITY SERVICES PO BOX 828854 PHILADELPHIA PA 191828854 SECURITY 518164 EQUIP ENTERPRISES 5726 WEST HAUSMAN RD STE 115A SAN ANTONIO TX 78249 JANITORIAL 370006 MASTERCONTROL INC PO BOX 35146 SEATLLE WA 981245146 SOFTWARE MAINTENANCE 362185 SOFTWAY SOLUTIONS INC DBA CULTURE 126 ELDRIDGE ROAD STE A SUGAR LAND TX 77478 CONSULTING 223000 11 0 SUPPORT AND ADMINISTRATIVE FEES 551112 35567036 35567036 35567036 960233 960233 0 0 50338 41027 9311 0 9311 9311 33731731 8000 33777474 18197 -45743 -10197 -55940 -55940 0 0 0 0 0 0 0 0 0 PURCHASE REBATES 551112 57960 57960 OTHER REVENUE 551112 102131 102131 102131 102131 160091 36640731 35727127 0 913604 368509 368509 0 0 0 3831292 3831292 0 0 17184062 16927075 256987 770019 770019 1973071 1915002 58069 1155428 1155428 0 123104 123104 190232 190232 0 0 211071 211071 1213452 1213452 326957 326957 730713 730713 1939974 1939974 0 1445704 1445704 254038 254038 0 47102 47102 36910 36910 0 1524736 1524736 62020 62020 TESTING EXPENSES & SUPPLIES 640879 640879 SERVICES PURCH. BY REL. ORG. -315056 -315056 EQUIPMENT MAINTENANCE 323366 323366 OTHER EXPENSES 807245 807245 34844828 34844828 0 0 448183 148996 1578534 925503 0 0 556109 225200 0 0 0 0 351797 393141 1290067 1475846 1664606 2177060 31152238 18393946 11866178 12758292 47542587 41166160 0 0 4685886 7844781 0 0 2573417 2651105 72557364 69766084 6822431 8130273 0 0 0 0 0 0 0 0 0 0 1830744 1673224 0 0 160599 4035524 8813774 13839021 X 63736731 55920826 6859 6237 63743590 55927063 72557364 69766084 X 1795903 -7730781 -1881649 X false true X true false X X 4 SOUTH TEXAS BLOOD & TISSUE CENTER 237379332 10 true 0 26046615 QUALTEX LABORATORIES 208429619 10 true 0 14479012 THE BLOOD & TISSUE CENTER FOUNDATION 431970952 10 true 0 527851 GENCURE 462216869 10 true 0 5619619 4 46673097 true false false false false false false false false false false false false false false true SCHEDULE A, PART 1 OTHER SUPPORT: BIOBRIDGE GLOBAL IS REIMBURSED FOR ALL THE COST INCURRED IN SUPPORT OF EACH SUPPORTED ORGANIZATION. SCHEDULE A, PART I, LINE 12G, COLUMN III TYPE OF ORGANIZATION: PER THE FORM 990 INSTRUCTIONS AND THE REQUIREMENTS FOR ELECTRONIC FILING, QUALTEX LABORATORIES AND THE BLOOD & TISSUE CENTER FOUNDATION HAVE BEEN DESIGNATED AS TYPE 10 ORGANIZATIONS. THOUGH THEY EACH MEET THE REQUIREMENTS OF A TYPE 10 ORGANIZATION, THEY ARE BEST CLASSIFIED AS TYPE 11 AND TYPE 12A, RESPECTIVELY. THESE ARE THEIR RESPECTIVE CLASSIFICATIONS PER THEIR IRS EXEMPTION LETTERS. 1020590 1020590 5861264 1232739 4628525 2819749 826688 1993061 18313408 14487723 3825685 3137227 1846796 1290431 12758292 INVESTMENT IN BCA 350000 F INVESTMENT IN BIO-PARTNERS 49500 F INVESTMENT IN ROOSTERBIO, INC. 6218743 F INVESTMENT IN STEMBIOSYS, INC. 1226538 F 7844781 0 INTERCOMPANY PAYABLE 1447458 OPERATING LEASE LIABILITIES 2588066 4035524 28473668 -7730781 2724990 -5005791 33479459 3161272 3161272 36640731 31249029 -3161894 -3161894 34410923 433905 433905 34844828 SCHEDULE D, PART X, LINE 2 ASC 740 FOOTNOTE: MANAGEMENT HAS EVALUATED THEIR INCOME TAX POSITIONS UNDER THE GUIDANCE INCLUDED IN ASC 740. BASED ON THEIR REVIEW, MANAGEMENT HAS NOT IDENTIFIED ANY MATERIAL UNCERTAIN TAX POSITIONS TO BE RECORDED OR DISCLOSED IN THE FINANCIAL STATEMENTS. SCHEDULE D, PART XI, LINE 2D AMOUNTS INCLUDED ON LINE 1 NOT ON FORM 990: SEPARATION PAYMENTS $ (222,834) INVESTMENT FEES $ (211,071) FMV ADJUSTMENT (PROGRAM RELATED INVESTMENTS) $ 3,158,895 -------------- TOTAL $ 2,724,990 SCHEDULE D, PART XI, LINE 4B AMOUNTS INCLUDED ON FORM 990 NOT ON LINE 1: COST ALLOCATION $ 3,202,921 RENTAL EXPENSES $ (41,027) CHANGE IN TEMP RESTRICTED NET ASSETS $ (622) ------------- TOTAL $ 3,161,272 SCHEDULE D, PART XII, LINE 2D AMOUNTS INCLUDED ON LINE 1 NOT ON FORM 990: COST ALLOCATION $(3,202,921) RENTAL EXPENSES $ 41,027 ------------- TOTAL $(3,161,894) SCHEDULE D, PART XII, LINE 4B AMOUNTS INCLUDED ON FORM 990 NOT ON LINE 1: SEPARATION PAYMENTS $ 222,834 INVESTMENT FEES $ 211,071 ----------- TOTAL $ 433,905 true THE BLOOD & TISSUE CENTER FOUNDATION 6211 IH 10 WEST SAN ANTONIO TX 78201 431970952 501(C)(3) 358368 OPERATIONS UNITED WAY OF SAN ANTONIO 700 S ALAMO ST SAN ANTONIO TX 78205 741272381 501(C)(3) 10141 OPERATIONS 2 SCHEDULE I, PART I, LINE 2 USE OF GRANT FUNDS: THE FUNDS PROVIDED BY BIOBRIDGE GLOBAL SERVE AS ASSISTANCE TO THE BLOOD & TISSUE CENTER FOUNDATION, A RELATED ORGANIZATION, TO HELP SUPPORT THE OPERATIONS OF THE FOUNDATION. X X X X X X false false true false false true true false false MARK EDWARD FITE SVP, COO, QUALTEX 286797 61075 5032 17752 998 371654 EMMANUEL ALEJANDRO CASASOLA EXECUTIVE DIRECTOR, GLOBAL QUA 183025 20729 1347 9442 10033 224576 CHRISTOPHER JOHNSON VP SUPPLY CHAIN & SUPPORT SERV 201463 22500 2659 13206 26156 265984 JOSE MURILLO VP INFORMATION TECHNOLOGY 213803 29000 2119 15354 30245 290521 JOHN F BARNES IV VP HUMAN RESOURCES & LEARNING 227501 39751 4652 14921 19847 306672 THOMAS SCOTT JONES VP SCIENTIFIC AFFAIRS 221471 37704 3777 15257 26096 304305 SOPHIE BARDY VP MARKETING 203108 35682 3011 15113 12254 269168 BENJAMIN LOPEZ SR DIR., FINANCE & ACCOUNTING 183199 18500 2168 6651 8729 219247 ADRIENNE MENDOZA SVP/COO, STBTC (EFF 04/22) 253866 42550 2657 18030 9448 326551 BECKY CAP SVP/BUS DEV (EFF 10/22) 49397 206024 0 29590 579 1945 2652 10756 403 1419 53031 249734 EDWARD CARTER III SVP/CHIEF COMMERCIAL OFFICER 308939 50525 4372 18578 1074 383488 ELIZABETH WALTMAN SVP/COO STBTC (THRU 03/22) 121614 88415 2261 10038 4047 226375 GLENN KUES SVP/CFO (THRU 06/22) 192390 75000 2678 14340 12376 296784 GRANVILLE BETTON SR VP TALENT & PERFORMANCE 200696 47447 4361 13273 21991 287768 JOHN WILLIAM YOUNGDAHL SVP/CFO (EFF 07/22) 235496 22000 1723 15826 17091 292136 MARTIN LANDON EX-OFFICIO DIR/CEO 743295 245000 4932 20242 21118 1034587 RACHEL-LOUISE BEDDARD SVP/CHIEF MEDICAL OFFICER 281586 67752 3226 15661 34744 402969 WILLIAM RICHEY WYATT SVP/GEN COUNSEL & CHIEF COMP 345058 83960 3226 18676 27799 478719 SCHEDULE J, PART I, LINE 4C EQUITY-BASED COMPENSATION PLAN: DURING 2018, THE ORGANIZATION ENTERED INTO A LONG-TERM DEFERRED COMPENSATION PLAN WITH THE CHIEF EXECUTIVE OFFICER (CEO). PURSUANT TO THE PLAN, THE CEO IS ENTITLED TO COMPENSATION BASED UPON THE INCREASE IN MARKET VALUE OF THE ORGANIZATION AS DEFINED IN THE AGREEMENT, SUBJECT TO CERTAIN LIMITS RELATED TO CUMULATIVE CASH FLOW. BASED UPON THE ORGANIZATION'S CALCULATED MARKET VALUE AS OF DECEMBER 31, 2022 AND 2021, NO DEFERRED COMPENSATION AMOUNTS WERE INCURRED DURING THE YEAR. SCHEDULE J, PART I, LINE 6A COMPENSATION CONTINGENT ON ORGANIZATION'S EARNINGS: BIOBRIDGE GLOBAL OFFERS AN INCENTIVE COMPENSATION PLAN THAT IS DEPENDENT ON ACHIEVING VARIOUS MEASURES. ONE OF THE MEASURES IS THAT BIOBRIDGE'S CONSOLIDATED FINANCIAL RESULTS MUST MEET OR EXCEED ITS BOARD APPROVED BUDGET. FORM 990, PART I, LINE 1 & PART III, LINE 1 ORGANIZATION'S MISSION: BIOBRIDGE GLOBAL (BBG) IS ORGANIZED FOR THE EXCLUSIVE PURPOSE OF SUPPORTING, AS THE SOLE MEMBER, SOUTH TEXAS BLOOD & TISSUE CENTER (STBTC), QUALTEX LABORATORIES (QUALTEX), GENCURE, AND THE BLOOD & TISSUE CENTER FOUNDATION (THE FOUNDATION), EACH OF WHICH IS A 501(C)(3) ORGANIZATION, BY PROVIDING SUPPORT AND ADMINISTRATIVE FUNCTIONS THAT PROMOTE AND SUPPORT THEIR CHARITABLE MISSION AND PURPOSE. FORM 990, PART VI, SECTION A, LINE 1B THE BOARD NOT INDEPENDENT: ONE MEMBER OF THE BOARD OF DIRECTORS IS NOT DEEMED INDEPENDENT BECAUSE HE RECEIVED COMPENSATION AS AN OFFICER OF THE ORGANIZATION. FORM 990, PART VI, SECTION B, LINE 11B PROCESS TO REVIEW THE FORM 990: THE ORGANIZATION ENGAGES AN OUTSIDE ACCOUNTING FIRM TO PREPARE THE FORM 990. ONCE PREPARED, THE RETURN IS REVIEWED BY FINANCIAL MANAGEMENT STAFF. A COPY OF THE FORM 990 IS PROVIDED TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C COMPLIANCE WITH CONFLICT OF INTEREST POLICY: A COPY OF THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS PROVIDED ANNUALLY TO ALL OFFICERS AND BOARD OF DIRECTORS. IN ADDITION, QUESTIONNAIRES ARE GIVEN OUT ON AN ANNUAL BASIS TO ALL OFFICERS AND BOARD OF DIRECTORS WHICH COVER BUSINESS AND FAMILY RELATIONSHIPS AND VARIOUS ACTIVITIES THAT HAVE OCCURRED OVER THE COURSE OF THE YEAR. EVERY ATTEMPT IS MADE TO ENSURE THAT ALL FORMS ARE RETURNED. INDIVIDUALS WHO FAIL TO RETURN THE REQUESTED FORMS OR PROVIDE INCOMPLETE INFORMATION ARE CONTACTED BY THE ORGANIZATION. IN THE EVENT OF A CONFLICT OF INTEREST, THE MEMBER SUBJECT TO THE CONFLICT OF INTEREST MUST LEAVE THE DISCUSSION AND VOTING ON A TRANSACTION OR ARRANGEMENT THAT RESULTS IN A CONFLICT OF INTEREST. A COMMITTEE OF NON-INTERESTED REPRESENTATIVES SHALL BE APPOINTED TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. THE PARTY WITH A CONFLICT OF INTEREST IS NOT PERMITTED TO ADVOCATE TO OTHER REPRESENTATIVES PRIOR TO THE VOTE. THE COMMITTEE IS RESPONSIBLE FOR EXERCISING DUE DILIGENCE IN DETERMINING THAT THE TRANSACTION IS NOT MORE MATERIALLY ADVANTAGEOUS THAN A DEAL WITH A NON-INTERESTED TRANSACTION. FORM 990, PART VI, SECTION B, LINE 15A REVIEW OF CEO/TOP MANAGEMENT OFFICIAL'S COMPENSATION: UPON HIRE BIOBRIDGE GLOBAL RELIED UPON AN INDEPENDENT COMPENSATION REPORT FROM A NATIONAL COMPENSATION CONSULTING FIRM. THE REPORT STUDIED COMPARABLE ORGANIZATIONS AND PROVIDED DETAILED APPENDICES OF COMPARABLE ORGANIZATIONS' COMPENSATION OF CEO'S IN SUPPORT OF THEIR ANALYSIS. THE INDEPENDENT CONSULTANT'S REPORT IS REVIEWED BY THE COMPENSATION COMMITTEE OF THE ORGANIZATION'S BOARD OF DIRECTORS AND SUBMITTED TO THE BOARD FOR APPROVAL. THE CEO'S COMPENSATION IS EVALUATED ANNUALLY BY THE BOARD'S COMPENSATION COMMITTEE. THE REVIEW IS DOCUMENTED IN THE MEETING MINUTES OF THE BOARD. FORM 990, PART VI, SECTION B, LINE 15B REVIEW OF OTHER OFFICER'S COMPENSATION: BIOBRIDGE GLOBAL UTILIZES AN INDEPENDENT COMPENSATION CONSULTING FIRM, COMPENSATION SURVEYS, COMPENSATION PACKAGES OFFERED BY SIMILAR ORGANIZATIONS IN OUR PEER GROUP, AND/OR MARKET COMPETITIVE ANALYSES. FORM 990, PART VI, SECTION B, LINE 16B POLICY FOR ARRANGEMENTS WITH TAXABLE ENTITIES: THE ORGANIZATION HAS NOT ESTABLISHED WRITTEN PROCEDURES BUT IS COMMITTED TO ENSURING THAT ANY ARRANGEMENTS ENTERED INTO SAFEGUARD THE ORGANIZATION'S EXEMPT STATUS AND WILL CONSULT WITH LEGAL COUNSEL WHEN NECESSARY. BLOOD CENTERS OF AMERICA IS MADE UP OF MEMBERS, ALL OF WHOM ARE EXEMPT ORGANIZATIONS WITHIN THE MEANING OF SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE OF 1986, AS AMENDED. FORM 990, PART VI, SECTION C, LINE 19 HOW DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC: ANY DOCUMENT SUBJECT TO OPEN RECORD REQUIREMENTS ARE MADE AVAILABLE UPON REQUEST. FORM 990, PART VIII, LINE 2A FORM 990 STATEMENT OF REVENUE: BIOBRIDGE GLOBAL'S REVENUES ARE DERIVED FROM THE SUPPORT AND ADMINISTRATIVE SERVICES PROVIDED TO ITS RELATED ORGANIZATIONS. FORM 990, PART XI, LINE 9 OTHER CHANGES IN NET ASSETS: CHANGE IN INTEREST RATE SWAP $ 245,959 EQUITY TRANSFER BETWEEN RELATED ORGANIZATIONS $ (5,286,503) FMV Adjustment (PROGRAM RELATED INVESTMENTS) $ 3,158,895 -------------- TOTAL $ (1,881,649) SOUTH TEXAS BLOOD & TISSUE CENTER 6211 IH 10 WEST SAN ANTONIO TX 78201 237379332 BLOOD BANK TX 501(C)(3) 10 BIOBRIDGE true THE BLOOD & TISSUE CENTER FOUNDATION 6211 IH 10 WEST SAN ANTONIO TX 78201 431970952 SUPPORT ORG. TX 501(C)(3) 12 TYPE I BIOBRIDGE true GENCURE 6211 IH 10 WEST SAN ANTONIO TX 78201 462216869 CEL AND TIS S TX 501(C)(3) 10 BIOBRIDGE true ALLIANCE FOR COMM TRANSFUSION SERVICES 2205 HWY 121 BEDFORD TX 76021 454624346 SEE PART VII TX 501(C)(3) 12 TYPE II NA false QUALTEX LABORATORIES 6211 IH 10 WEST SAN ANTONIO TX 78201 208429619 TEST PUB SFTY AZ 501(C)(3) 11 BIOBRIDGE true false true false true false false false false false false true true false true true true true false false THE BLOOD & TISSUE CENTER FOUNDATION B 358368 CASH QUALTEX LABORATORIES D 2907151 BOOK COST GENCURE D 3343630 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER K 1296906 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER N 3529964 BOOK COST QUALTEX LABORATORIES N 2414046 BOOK COST GENCURE N 852437 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER O 12617198 BOOK COST QUALTEX LABORATORIES O 8628557 BOOK COST GENCURE O 3046878 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER P 6558104 BOOK COST QUALTEX LABORATORIES P 723372 BOOK COST THE BLOOD & TISSUE CENTER FOUNDATION P 368583 BOOK COST SOUTH TEXAS BLOOD & TISSUE CENTER Q 9899453 BOOK COST QUALTEX LABORATORIES Q 3436409 BOOK COST GENCURE Q 1720304 BOOK COST THE BLOOD & TISSUE CENTER FOUNDATION Q 527851 BOOK COST GENCURE P 65942 BOOK COST SCHEDULE R, PART II, LINE 4, COLUMN B PRIMARY ACTIVITY: THE PRIMARY ACTIVITY OF ALLIANCE FOR COMMUNITY TRANSFUSION SERVICES IS THE PROMOTION OF STANDARDIZATION AND EFFICIENCY.